El coste de la diabetes tipo 2 en España. El estudio CODE-2
(The cost of type 2 diabetes in Spain: the CODE-2 study)
Leído
9187
Vecesse ha leído el artículo
2350
Total PDF
6837
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S0213911102719730" "issn" => "02139111" "doi" => "10.1016/S0213-9111(02)71973-0" "estado" => "S300" "fechaPublicacion" => "2002-11-01" "aid" => "71973" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "copyrightAnyo" => "2002" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Gac Sanit. 2002;16:511-20" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5584 "formatos" => array:3 [ "EPUB" => 162 "HTML" => 4794 "PDF" => 628 ] ] "itemSiguiente" => array:19 [ "pii" => "S0213911102719742" "issn" => "02139111" "doi" => "10.1016/S0213-9111(02)71974-2" "estado" => "S300" "fechaPublicacion" => "2002-11-01" "aid" => "71974" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Gac Sanit. 2002;16:521-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2882 "formatos" => array:3 [ "EPUB" => 118 "HTML" => 2307 "PDF" => 457 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "521" "paginaFinal" => "525" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "(Employees attitudes to workplace health promotion programs for cancer prevention)" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Sala, G. Janer, C. Font, I. Garau, M.D. Solé, T. Corbella, T. Partanen, M. Kogevinas" "autores" => array:8 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Sala" ] 1 => array:2 [ "nombre" => "G." "apellidos" => "Janer" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Font" ] 3 => array:2 [ "nombre" => "I." "apellidos" => "Garau" ] 4 => array:2 [ "nombre" => "M.D." "apellidos" => "Solé" ] 5 => array:2 [ "nombre" => "T." "apellidos" => "Corbella" ] 6 => array:2 [ "nombre" => "T." "apellidos" => "Partanen" ] 7 => array:2 [ "nombre" => "M." "apellidos" => "Kogevinas" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911102719742?idApp=WGSE" "url" => "/02139111/0000001600000006/v1_201310251643/S0213911102719742/v1_201310251643/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0213911102719729" "issn" => "02139111" "doi" => "10.1016/S0213-9111(02)71972-9" "estado" => "S300" "fechaPublicacion" => "2002-11-01" "aid" => "71972" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Gac Sanit. 2002;16:505-10" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2638 "formatos" => array:3 [ "EPUB" => 134 "HTML" => 2091 "PDF" => 413 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Aceptación de los fármacos genéricos en equipos de atención primaria: efecto de una intervención educativa y de los precios de referencia" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "505" "paginaFinal" => "510" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "(Acceptance of generic prescribing in general practice: effect of patient education and reference prices)" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.A. Vallès, M. Barreiro, G. Cereza, J.J. Ferro, M.J. Martínez, E. Cucurull, E. Barceló" "autores" => array:7 [ 0 => array:2 [ "nombre" => "J.A." "apellidos" => "Vallès" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Barreiro" ] 2 => array:2 [ "nombre" => "G." "apellidos" => "Cereza" ] 3 => array:2 [ "nombre" => "J.J." "apellidos" => "Ferro" ] 4 => array:2 [ "nombre" => "M.J." "apellidos" => "Martínez" ] 5 => array:2 [ "nombre" => "E." "apellidos" => "Cucurull" ] 6 => array:2 [ "nombre" => "E." "apellidos" => "Barceló" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911102719729?idApp=WGSE" "url" => "/02139111/0000001600000006/v1_201310251643/S0213911102719729/v1_201310251643/es/main.assets" ] "es" => array:14 [ "idiomaDefecto" => true "titulo" => "El coste de la diabetes tipo 2 en España. El estudio CODE-2" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "511" "paginaFinal" => "520" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Mata, F. Antoñanzas, M. Tafalla, P. Sanz" "autores" => array:4 [ 0 => array:3 [ "nombre" => "M." "apellidos" => "Mata" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "F." "apellidos" => "Antoñanzas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Tafalla" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "P." "apellidos" => "Sanz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "CAP La Mina. Sant Adrià de Besòs. Barcelona" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Economía y Empresa. Universidad de la Rioja" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Pharma Research. Pharma-Consult Services, S.A. Madrid" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondencia: Juan Ragel. Pharma Consult Services, S.A. Avda. Burgos, 12, 9.a planta. 28036 Madrid.Correo electrónico: Jragel@pharma-consult.es" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "(The cost of type 2 diabetes in Spain: the CODE-2 study)" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2002-02-05" "fechaAceptado" => "2002-09-30" "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec268818" "palabras" => array:3 [ 0 => "Diabetes tipo 2" 1 => "Coste" 2 => "Farmacoeconomía" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec268819" "palabras" => array:4 [ 0 => "Type 2 diabetes" 1 => "Cost" 2 => "Pharmacoeconomic study" 3 => "Spain" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle">Objetivo</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Estimar el coste de la atención sanitaria al paciente diabético tipo 2, diferenciando el gasto derivado del control de la enfermedad, de la atención de sus complicaciones y de otros costes directos asociados.</p> <span class="elsevierStyleSectionTitle">Métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Recogida retrospectiva del consumo de recursos a partir de la historia clínica y la entrevista personal en 29 centros de atención primaria de todo el territorio nacional de una muestra de pacientes seleccionados de forma aleatoria a partir del registro de diabéticos de cada centro.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Se evaluó a 1.004 pacientes (561 mujeres) con una media de edad de 67,42 años y una media de evolución de la enfermedad de 10,07 años. El 50,9% no presentaba complicaciones, el 17,7% sólo macrovasculares, el 19,5% sólo microvasculares y el 11,9% ambas. El coste anual sanitario por paciente fue de 1.305,15 euros. De este coste el 28,6% (373,27 euros) estaba relacionado directamente con el control de la diabetes, el 30,51% (398,20 euros) con sus complicaciones y el 40,89% (533,68 euros) no estaba relacionado. El coste medio de un paciente sin complicaciones fue de 883 euros frente a 1.403 de un paciente con complicaciones microvasculares, 2.022 cuando existían complicaciones macrovasculares y 2.133 cuando coexistían ambos tipos de complicaciones.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">El elevado coste del tratamiento de la diabetes tipo 2 y sus complicaciones, sugiere la posibilidad de que la mejora del control de la enfermedad pueda no sólo mejorar la supervivencia y la calidad de vida, sino reducir los costes asociados con las complicaciones crónicas.</p>" ] "en" => array:2 [ "titulo" => "Summary" "resumen" => "<span class="elsevierStyleSectionTitle">Objective</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">To estimate the cost of providing health care to patients with type 2 diabetes, by differentiating costs of the disease, costs of complications, and other unrelated health costs.</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Data on resource use were retrospectively collected from medical records and personal interviews in 29 primary health care centers in Spain. Patients were randomly selected from each center's diabetes registry.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">We evaluated 1004 patients (561 women) with a mean age of 67.42 years and a mean disease duration of 10.07 years. A total of 50.9% had no complications, 17.7% had macrovascular complications only, 19.5% had microvascular complications only and 11.9% presented both types of complication. The annual health cost per patient was 1305.15 euros. Of this cost, 28.6% (373.27 euros) was directly related to diabetes control, 30.51% (398.20 euros) was related to complications of the disease, and 40.89% (533.68 euros) was unrelated. The mean cost of patients with no complications was 883 euros compared with 1403 euros for those with microvascular complications, 2022 euros for those with macrovascular complications and 2133 euros for patients with both types of complication.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Because of the high cost of treating type 2 diabetes and its complications, preventive measures should be implemented and control of the disease should be improved to reduce the costs associated with chronic complications.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Biblografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:30 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Consenso para la Atención a las Personas con Diabetes en España" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:1 [ "serieFecha" => "1994" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patiens with 2 diabetes (UKPDS 33)" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "UK Prospective Diabetes Study Group" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1998" "volumen" => "352" "paginaInicial" => "837" "paginaFinal" => "853" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9742976" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes patiens (UKPDS 34)" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "UK Prospective Diabetes Study Group" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1998" "volumen" => "352" "paginaInicial" => "854" "paginaFinal" => "865" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9742977" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "UK Prospective Diabetes Study Group" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1998" "volumen" => "317" "paginaInicial" => "703" "paginaFinal" => "713" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9732337" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análisis coste-efectividad de la automonitorización de la glucosa sanguínea en diabéticos tipo 2" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.L. Clua Espuny" 1 => "J. Puig Junoy" 2 => "M.L. Queralt Tomás" 3 => "A. Palau Galindo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Gac Sanit" "fecha" => "2000" "volumen" => "14" "paginaInicial" => "442" "paginaFinal" => "448" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11270170" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impacto económico de la diabetes mellitus en los costes de hospitalización" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.M. Pascual" 1 => "C. Gonzalez" 2 => "S. De Juan" 3 => "C. Sánchez" 4 => "B. Sánchez" 5 => "M. Pérez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1996" "volumen" => "107" "paginaInicial" => "207" "paginaFinal" => "210" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "El coste de la diabetes mellitus conocida en España" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "W.M. Hart" 1 => "C. Espinosa" 2 => "J. Rovira" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1997" "volumen" => "109" "paginaInicial" => "289" "paginaFinal" => "293" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes – The cost of illness and the cost of control" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "B. Jönnson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Med Scand" "fecha" => "1983" "volumen" => "671" "numero" => "Suppl" "paginaInicial" => "19" "paginaFinal" => "27" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R.M. Kaplan" 1 => "W.K. Davis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "1986" "volumen" => "9" "paginaInicial" => "81" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3081308" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes mellitus and the St Vivent Declaration. The economic implications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "B. Leese" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pharmaco-Economics" "fecha" => "1995" "volumen" => "7" "paginaInicial" => "292" "paginaFinal" => "307" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La versión española del EuroQol: descripción y sus aplicaciones. Escala Europea de Calidad" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "X. Badia" 1 => "M. Roset" 2 => "S. Montserrat" 3 => "M. Herdman" 4 => "A. Segura" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1999" "volumen" => "112" "numero" => "Supl 1" "paginaInicial" => "79" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kosten des Typ-2-Diabetes in Deutschland. Ergebnisse der CODE-2 Studie" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Liebl" 1 => "A. Neiss" 2 => "A. Spannheimer" 3 => "U. Reitberger" 4 => "T. Wagner" 5 => "A. Goërtz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-2001-14102" "Revista" => array:6 [ "tituloSerie" => "Dtsch Med Wschr" "fecha" => "2001" "volumen" => "126" "paginaInicial" => "585" "paginaFinal" => "589" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11402924" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consommation de soins et de Biens médicaux des diabétiques de type 2 en France en 1998" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Detournay" 1 => "F. Fagnani" 2 => "C. Pribil" 3 => "E. Eschwege" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10719-015-9578-6" "Revista" => array:6 [ "tituloSerie" => "Diabetes & Metabolism (Paris)" "fecha" => "2000" "volumen" => "26" "paginaInicial" => "225" "paginaFinal" => "231" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25796617" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes y farmacoeconomía. Eficiencia de los métodos inyectables de insulina disponibles en España" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Costa" 1 => "A. Estopa" 2 => "J. Borras" 3 => "A. Sabate" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1995" "volumen" => "16" "paginaInicial" => "391" "paginaFinal" => "396" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7495947" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consumo de medicamentos en la diabetes mellitus 2. Utilización y pérdida de insulina: epidemiología e implicaciones socioeconómicas. Grupo de estudio de la diabetes de Tarragona" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Costa" 1 => "J.F. Monclus" 2 => "M. Huguet" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1993" "volumen" => "100" "paginaInicial" => "241" "paginaFinal" => "244" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consumo de medicamentos en diabetes mellitus (IV). Utilización de material reactivo y sistemas de control de la glucosa en sangre desde el punto de vista de la atención primaria. Grupo de estudio de la diabetes en Tarragona" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B. Costa" 1 => "M. Huguet" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1994" "volumen" => "102" "paginaInicial" => "321" "paginaFinal" => "324" "itemHostRev" => array:3 [ "pii" => "S0091674903008704" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Automonitorización de la glucosa en sangre: evaluación de su prescripción y resultados en diabetes tipo 2. Grupo de investigación en atención primaria de Tortosa" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Clua Espuny" 1 => "J. Puig Junoy" 2 => "E. Ciurana Roca" 3 => "G. García Bernal" 4 => "J.F. Monclus Benet" 5 => "A. González Henares" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1999" "volumen" => "24" "paginaInicial" => "316" "paginaFinal" => "325" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10596221" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Economic consequences of diabetes mellitus in the US in 1997" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "American Diabetes Association" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "1998" "volumen" => "21" "paginaInicial" => "296" "paginaFinal" => "309" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9539999" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The cost of diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K. Gerard" 1 => "C. Donaldson" 2 => "A.K. Maynard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Diabetic Med" "fecha" => "1989" "volumen" => "6" "paginaInicial" => "164" "paginaFinal" => "170" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2522861" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Gray" 1 => "M. Raikou" 2 => "A. McGuire" 3 => "P. Fenn" 4 => "R. Stevens" 5 => "C. Cull" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2000" "volumen" => "320" "paginaInicial" => "1373" "paginaFinal" => "1378" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10818026" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Direct medical costs for patients with type 2 diabetes in Sweden" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Henriksson" 1 => "C.D. Agardh" 2 => "C. Berne" 3 => "J. Bolinder" 4 => "F. Lönnqvist" 5 => "P. Stenström" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Intern Med" "fecha" => "2000" "volumen" => "248" "paginaInicial" => "387" "paginaFinal" => "396" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11123503" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Costi e profili di trattamento farmacologico nei pazienti con diabete di tipo 2: i risultati dello studio CODE-2" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Lucioni" 1 => "S. Mazzi" 2 => "G. Serra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pharmacoeconomics-Italian Research Articles" "fecha" => "2001" "volumen" => "3" "paginaInicial" => "1" "paginaFinal" => "14" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes (UKPDS 40)" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "UK Prospective Diabetes Study Group" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "BMJ" "fecha" => "1998" "volumen" => "317" "paginaInicial" => "720" "paginaFinal" => "726" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9732339" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0091674902014161" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes in Canada: direct medical costs of major macrovascular complications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.A. O'Brien" 1 => "I. Caro" 2 => "D. Getsios" 3 => "J.J. Caro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1524-4733.2001.43017.x" "Revista" => array:6 [ "tituloSerie" => "Value in Health" "fecha" => "2001" "volumen" => "4" "paginaInicial" => "258" "paginaFinal" => "265" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11705187" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An economic analysis of interventions for Diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Klonoff" 1 => "D. Schwartz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2000" "volumen" => "23" "paginaInicial" => "390" "paginaFinal" => "404" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10868871" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "The Diabetes Control and Complications Trial Research Group (DCCT)" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1996" "volumen" => "276" "paginaInicial" => "1409" "paginaFinal" => "1415" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8892716" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Model of complications of NIDDM II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.C. Eastman" 1 => "J.C. Javitt" 2 => "W.H. Herman" 3 => "E.J. Dasbach" 4 => "C. Copley-Merriman" 5 => "W. Maier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "1997" "volumen" => "20" "paginaInicial" => "685" "paginaFinal" => "686" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9135926" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The validity of the EQ-5D in children with asthma. 16th Plenary Meeting of the EuroQol Group" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Roset" 1 => "X. Badia" 2 => "A. Benavides" 3 => "M. Herdman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Sitges, Spain" "fecha" => "1999, noviembre" "paginaInicial" => "6" "paginaFinal" => "9" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Badia X, Roset M, López-David C, Herdman M. Is the EQ-5D useful in estimating use of health resources in a cohort of HIV patients? 17th Plenary Meeting of the EuroQol Group." ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making" ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02139111/0000001600000006/v1_201310251643/S0213911102719730/v1_201310251643/es/main.assets" "Apartado" => array:4 [ "identificador" => "18705" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Originales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02139111/0000001600000006/v1_201310251643/S0213911102719730/v1_201310251643/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911102719730?idApp=WGSE" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 10 | 8 | 18 |
| 2024 Octubre | 58 | 33 | 91 |
| 2024 Septiembre | 46 | 27 | 73 |
| 2024 Agosto | 63 | 28 | 91 |
| 2024 Julio | 46 | 27 | 73 |
| 2024 Junio | 51 | 18 | 69 |
| 2024 Mayo | 47 | 35 | 82 |
| 2024 Abril | 60 | 22 | 82 |
| 2024 Marzo | 50 | 18 | 68 |
| 2024 Febrero | 46 | 39 | 85 |
| 2024 Enero | 40 | 28 | 68 |
| 2023 Diciembre | 49 | 16 | 65 |
| 2023 Noviembre | 45 | 26 | 71 |
| 2023 Octubre | 46 | 25 | 71 |
| 2023 Septiembre | 51 | 24 | 75 |
| 2023 Agosto | 45 | 10 | 55 |
| 2023 Julio | 44 | 23 | 67 |
| 2023 Junio | 38 | 16 | 54 |
| 2023 Mayo | 41 | 29 | 70 |
| 2023 Abril | 40 | 31 | 71 |
| 2023 Marzo | 51 | 39 | 90 |
| 2023 Febrero | 28 | 20 | 48 |
| 2023 Enero | 34 | 22 | 56 |
| 2022 Diciembre | 54 | 35 | 89 |
| 2022 Noviembre | 58 | 44 | 102 |
| 2022 Octubre | 39 | 55 | 94 |
| 2022 Septiembre | 27 | 25 | 52 |
| 2022 Agosto | 40 | 66 | 106 |
| 2022 Julio | 35 | 43 | 78 |
| 2022 Junio | 34 | 35 | 69 |
| 2022 Mayo | 38 | 45 | 83 |
| 2022 Abril | 41 | 47 | 88 |
| 2022 Marzo | 47 | 45 | 92 |
| 2022 Febrero | 29 | 34 | 63 |
| 2022 Enero | 39 | 42 | 81 |
| 2021 Diciembre | 32 | 53 | 85 |
| 2021 Noviembre | 36 | 57 | 93 |
| 2021 Octubre | 25 | 39 | 64 |
| 2021 Septiembre | 24 | 42 | 66 |
| 2021 Agosto | 20 | 27 | 47 |
| 2021 Julio | 22 | 31 | 53 |
| 2021 Junio | 22 | 26 | 48 |
| 2021 Mayo | 23 | 24 | 47 |
| 2021 Abril | 46 | 93 | 139 |
| 2021 Marzo | 39 | 21 | 60 |
| 2021 Febrero | 17 | 12 | 29 |
| 2021 Enero | 42 | 16 | 58 |
| 2020 Diciembre | 22 | 35 | 57 |
| 2020 Noviembre | 11 | 14 | 25 |
| 2020 Octubre | 18 | 17 | 35 |
| 2020 Septiembre | 8 | 14 | 22 |
| 2020 Agosto | 17 | 16 | 33 |
| 2020 Julio | 23 | 19 | 42 |
| 2020 Junio | 25 | 16 | 41 |
| 2020 Mayo | 19 | 14 | 33 |
| 2020 Abril | 18 | 29 | 47 |
| 2020 Marzo | 15 | 14 | 29 |
| 2020 Febrero | 15 | 34 | 49 |
| 2020 Enero | 9 | 23 | 32 |
| 2019 Diciembre | 16 | 22 | 38 |
| 2019 Noviembre | 14 | 12 | 26 |
| 2019 Octubre | 12 | 9 | 21 |
| 2019 Septiembre | 14 | 14 | 28 |
| 2019 Agosto | 7 | 14 | 21 |
| 2019 Julio | 8 | 13 | 21 |
| 2019 Junio | 8 | 12 | 20 |
| 2019 Mayo | 13 | 14 | 27 |
| 2019 Abril | 10 | 12 | 22 |
| 2019 Marzo | 9 | 10 | 19 |
| 2019 Febrero | 26 | 14 | 40 |
| 2019 Enero | 12 | 18 | 30 |
| 2018 Diciembre | 15 | 17 | 32 |
| 2018 Noviembre | 20 | 14 | 34 |
| 2018 Octubre | 46 | 26 | 72 |
| 2018 Septiembre | 13 | 8 | 21 |
| 2018 Agosto | 28 | 19 | 47 |
| 2018 Julio | 22 | 9 | 31 |
| 2018 Junio | 18 | 11 | 29 |
| 2018 Mayo | 30 | 17 | 47 |
| 2018 Abril | 20 | 12 | 32 |
| 2018 Marzo | 8 | 5 | 13 |
| 2018 Febrero | 17 | 9 | 26 |
| 2018 Enero | 15 | 5 | 20 |
| 2017 Diciembre | 25 | 9 | 34 |
| 2017 Noviembre | 19 | 14 | 33 |
| 2017 Octubre | 16 | 17 | 33 |
| 2017 Septiembre | 22 | 16 | 38 |
| 2017 Agosto | 20 | 18 | 38 |
| 2017 Julio | 26 | 39 | 65 |
| 2017 Junio | 37 | 14 | 51 |
| 2017 Mayo | 40 | 6 | 46 |
| 2017 Abril | 40 | 17 | 57 |
| 2017 Marzo | 33 | 10 | 43 |
| 2017 Febrero | 21 | 11 | 32 |
| 2017 Enero | 17 | 5 | 22 |
| 2016 Diciembre | 54 | 9 | 63 |
| 2016 Noviembre | 48 | 20 | 68 |
| 2016 Octubre | 38 | 13 | 51 |
| 2016 Septiembre | 42 | 6 | 48 |
| 2016 Agosto | 45 | 6 | 51 |
| 2016 Julio | 35 | 9 | 44 |
| 2016 Febrero | 2 | 0 | 2 |
| 2015 Diciembre | 1 | 0 | 1 |
| 2015 Enero | 5 | 0 | 5 |
| 2014 Diciembre | 9 | 0 | 9 |
| 2014 Noviembre | 6 | 0 | 6 |
| 2014 Octubre | 5 | 0 | 5 |
| 2014 Septiembre | 10 | 0 | 10 |
| 2014 Agosto | 13 | 0 | 13 |
| 2014 Julio | 18 | 0 | 18 |
| 2014 Junio | 13 | 0 | 13 |
| 2014 Mayo | 20 | 3 | 23 |
| 2014 Abril | 10 | 1 | 11 |
| 2014 Marzo | 9 | 2 | 11 |
| 2014 Febrero | 20 | 1 | 21 |
| 2014 Enero | 18 | 0 | 18 |
| 2013 Diciembre | 16 | 1 | 17 |
| 2013 Noviembre | 32 | 2 | 34 |
| 2013 Octubre | 55 | 5 | 60 |
| 2013 Septiembre | 28 | 7 | 35 |
| 2013 Agosto | 28 | 4 | 32 |
| 2013 Julio | 27 | 3 | 30 |
| 2002 Noviembre | 3455 | 0 | 3455 |
Mostrar todo
